Fundraising Fox

Ian Eliason

Investor

Partner at Zoic Capital

United States

Find your path to Ian

36 people in our graph share verified history with Ian β€” schools, employers, funds. One of them is your warm intro.

Michele ColucciunlockedIan: together at Optina Diagnostics (2020–2026)
Γ—2Ian: together at Chromatan, Inc.
Γ—3Ian: together at Zoic Capital
Γ—2Ian: together at Optina Diagnostics

About

Ian Eliason is Partner and Co-founder at Zoic Capital, a US-based venture firm focused on seed-stage Medtech investments. His work involves analysis, due diligence, and portfolio optimization, including identifying areas of improvement for portfolio companies and evaluating potential investment opportunities. Zoic Capital's investment criteria include a significant improvement over the current standard of care, scientific support from published literature and trials, and initial regulatory approval on a two-to-four-year timeline.

Experience

  1. Zoic CapitalPartner & Co-foundercurrent2014 β€” present
  2. HDT BioInvestor & Advisorcurrent2020 β€” present
  3. Trio Labs, Inc.Investor & Advisorcurrent2024 β€” present
  4. ChromaTan, IncInvestor & Advisorcurrent2023 β€” present
  5. ProbiusInvestor & Advisorcurrent2020 β€” present
  6. ODS Medical IncBoard Membercurrent2020 β€” present
  7. ODS Medical IncInvestor & Advisorcurrent2017 β€” present
  8. ODS Medical IncBoard Observer2017 β€” 2020
  9. Optina DiagnosticsInvestor & Advisorcurrent2018 β€” present
  10. BioROSA TechnologiesInvestor & Advisorcurrent2020 β€” present
  11. InnoveinInvestor & Advisorcurrent2018 β€” present
  12. Juno DiagnosticsInvestor & Advisorcurrent2018 β€” present

Skills & more

Venture Capital19Start-ups15Due Diligence5Valuation5Biotechnology5Business Development7Investments5Risk Management4New Business Development3Web Design1Financial Modeling2Business Strategy2
+4 moreLeadershipAnalysisStrategyStrategic Planning

From Ian's professional profile.

Colleagues at Zoic Capital

Frequently asked questions

Who is Ian Eliason?
Ian Eliason is Partner and Co-founder at Zoic Capital, a US-based venture firm focused on seed-stage Medtech investments. His work involves analysis, due diligence, and portfolio optimization, including identifying areas of improvement for portfolio companies and evaluating potential investment opportunities. Zoic Capital's investment criteria include a significant improvement over the current standard of care, scientific support from published literature and trials, and initial regulatory approval on a two-to-four-year timeline.
Where does Ian Eliason work?
Ian Eliason is Partner at Zoic Capital.
Where did Ian Eliason go to school?
Ian Eliason studied at University of Minnesota (Bachelor of Science - BS, Public Health, Finance, Communications).

Same school

Shared employers